According to a report by Lesaffaires on January 12th, the Canadian Department of Health conducted a statistical survey revealing that Canadian marijuana consumers have reduced their monthly spending on marijuana from $73 in 2018 to $63 in the past 12 months.
A recent annual cannabis consumer survey conducted in Ottawa revealed that in 2023, 73% of respondents claimed to have purchased cannabis through legal means, nearly double the figure from 2019. The proportion of cannabis purchases made through legal avenues has now risen to 70%.
The investigation further revealed that despite the increasing number of Canadians purchasing marijuana through legal means, smoking remains the most prevalent method of consumption for marijuana in 2023, accounting for 63%. This is followed by the consumption of marijuana-infused products at a rate of 52%, and the use of e-cigarettes or vape pens, accounting for 33%.
According to the Canadian Ministry of Health, the proportion of respondents who consume marijuana daily or almost daily has remained relatively stable since 2018, averaging around 25% overall, with approximately 20% being young people. There have been no significant new trends in marijuana consumption among young people aged 16 to 19 in the past 12 months.
A total of 11,690 Canadians participated in the survey conducted between May and July 2023. Industry experts point out that there may be some bias in the data regarding marijuana, as respondents may be unwilling to admit to purchasing marijuana from the "black market".
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
![[2Firsts Special Report] EPO Enlarged Board of Appeal Issues Key Decision: China YTI Gains Procedural Advantage in Heated Tobacco Patent Dispute with Philip Morris](https://static.2firsts.com/uploads/20250619/680a1f4818d125725c6608db46873b7a.png?x-oss-process=style/origin)
